← Back to headlines
Germany's Merck to Acquire Bio-Techne in $11.3 Billion Deal
German pharmaceutical and life science company Merck has reached an agreement to acquire Bio-Techne in a deal valued at $11.3 billion, expanding its portfolio in the biotechnology sector.
25 Jun, 10:57 — 25 Jun, 10:57
Sources
Showing 1 of 1 sources
Related Stories
Nvidia Reports Record Second-Quarter Earnings Driven by Surging AI Demand
45m ago
Universal Studios Japan Announces Nearly $2 Billion Expansion Project
1h ago
Nvidia Earnings Fuel Broad Market Rally Ahead of Jackson Hole Symposium
1h ago
Mixed Corporate Earnings Drive Market Movements as Burlington Slides
1h ago